InsiderTrades

Form 4 for SLDB Solid Biosciences Inc.

Accepted 2024-04-05 00:00:00 ET · period of report 2024-04-03 · accession 0000950170-24-042322 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-04-05 2024-04-03 SLDB SMITH IAN F Dir M - OptEx — +3,256 103.2K +3% —
D 2024-04-05 2024-04-03 SLDB SMITH IAN F Dir M - OptEx $0.00 -3,256 9,765 -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-04-03 M A 3,256 — 103,207 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
2 Derivative Restricted Stock Units 2024-04-03 M D 3,256 $0.00 9,765 D — · — to — 3,256 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) The restricted stock units were granted on January 3, 2024 (the "Grant Date") and vest in equal quarterly installments beginning three months from the Grant Date, with the final installment vesting the date that is 12 months from the Grant Date; provided that in the event of early termination of the Second Amendment to the Executive Chair Agreement between the Issuer and the reporting person (the "Smith Agreement") prior to the expiration of the Term (as defined in the Smith Agreement) and/or a change in control of the Issuer, the restricted stock units shall accelerate in full.